[Federal Register Volume 59, Number 174 (Friday, September 9, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-22353]


[[Page Unknown]]

[Federal Register: September 9, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Docket No. 94N-0307]

 

American Cyanamid Co.; Withdrawal of Approval of NADA

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval 
of a new animal drug application (NADA) held by American Cyanamid Co. 
The NADA provides for use of chlortetracycline bisulfate soluble bulk 
for making medicated drinking water for animals for the prevention and 
treatment of various bacterial infections. The sponsor requested the 
withdrawal of approval of the NADA.
EFFECTIVE DATE: September 19, 1994.

FOR FURTHER INFORMATION CONTACT: Dianne T. McRae, Center for Veterinary 
Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 301-594-1623.

SUPPLEMENTARY INFORMATION: American Cyanamid Co., Agricultural Research 
Division, Box 400, Princeton, NJ 08543-0400, is the sponsor of NADA 65-
217 that provides for use of chlortetracycline bisulfate soluble bulk 
for making medicated drinking water for animals for the prevention and 
treatment of various bacterial infections. American Cyanamid Co. 
requested withdrawal of NADA 65-217 because there are no products being 
marketed based on this application.
    Therefore, under authority delegated to the Commissioner of Food 
and Drugs (21 CFR 5.10) and redelegated to the Center for Veterinary 
Medicine (21 CFR 5.84), and in accordance with 21 CFR 514.115 
Withdrawal of approval of applications, notice is given that approval 
of NADA 65-217 and all supplements and amendments thereto is hereby 
withdrawn, effective September 19, 1994.

    Dated: September 1, 1994.
Richard H. Teske,
Deputy Director, Pre-market Review, Center for Veterinary Medicine.
[FR Doc. 94-22353 Filed 9-8-94; 8:45 am]
BILLING CODE 4160-01-F